Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652834 · ClinicalTrials.gov registry record · Phase 4
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00652834 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 23 participants.
The verdict
NCT00652834, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about symptoms and gastrointestinal lesions associated with taking myfortic® by switching patients to a delayed release formulation that is developed to alleviate GI symptoms. A comparison of the frequency and severity of GI symptoms observed in patients treated with MMF (cellcept®) after conversion to myfortic® will be measured by using a self-assessed questionnaire called Gastrointestinal Symptom Rating Scale (GSRS). To prove the incidence and improvement of GI lesions in patients treated with MMF (cellcept®) after conversion to myfortic® will be measured by using Small Bowel Capsule Endoscopy (SBCE).
Interventions
- PROCEDURE Small bowel capsule endoscopy (SBCE)
- DRUG myfortic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652834
The ClinicalTrials.gov registry entry for NCT00652834 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Small bowel capsule endoscopy (SBCE) is the first listed.
NCT00652834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00652834 about?
NCT00652834 is a clinical study titled "Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®". The purpose of this study is to learn more about symptoms and gastrointestinal lesions associated with taking myfortic® by switching patients to a delayed release formulation that is developed to alleviate GI symptoms. A comparison of the frequency and severity of GI symptoms observed in patients tr...
What is the current status of trial NCT00652834?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2009-04. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00652834?
The interventions under investigation include: Small bowel capsule endoscopy (SBCE) (PROCEDURE), myfortic (DRUG).
Who is sponsoring clinical trial NCT00652834?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.